Welcome to the ACT Member Network

ACT's 36th Annual Meeting Highlight Series: Award Ceremony and Luncheon



By Tracey Zoetis, Awards Committee Chairperson

The Awards Committee is delighted to announce that Dr. Frank Young is the recipient of the 2015 Distinguished Scientist Award. If you are attending the Annual Meeting, we invite you to join the College for the Awards Ceremony and Luncheon on Monday, November 9 from 12:00 noon–2:00 pm. Dr. Young will be a keynote speaker, and the 2015 recipients of the Service Award, Young Professional Award, Carol C. Lemire Unsung Hero Award, Student Travel Awards, Student Furst Award, the North American Graduate Fellowships, and the International Travel Grants will be announced. ACT is pleased to celebrate the accomplishments of the recipients of each of these awards.

ACT's 2015 Distinguished Scientist, Dr. Frank Young, Executive VP for Clinical and Regulatory Affairs, Braeburn Pharmaceuticals


Dr. Frank Young is a venture partner in Apple Tree Partners, Executive VP for Clinical and Regulatory Affairs, Braeburn Pharmaceuticals, adjunct partner of Essex Woodlands, president of Woodhaven Consultants Inc., Pastor Emeritus of Fourth Presbyterian Church, Bethesda, MD, Dean Emeritus of the School of Medicine and Dentistry, University of Rochester and Rear Admiral, USPHS, (Ret).

He attended Union College, graduated from the SUNY Upstate Medical University, with a MD Cum Laude, and from Case Western Reserve University, with a PhD. His residency in pathology was at the Institute of Pathology, University Hospitals in Cleveland, Ohio. After numerous academic appointments, he served as chairman of the Department of Microbiology and professor of microbiology, pathology and radiation biology and biophysics at the University of Rochester, Rochester, New York. Subsequently, he became dean of the School of Medicine and Dentistry, director of the medical center and vice president for Health Affairs of the University of Rochester. Dr. Young joined the Department of Health and Human Services (DHHS) as Rear Admiral in 1984 in the United States Public Health Service Commissioned Corps. He served as: Commissioner of the US Food and Drug Administration from 1984–1989 where he focused on expediting drug review, enhancing the quality of device review with particular emphasis on cardiovascular devices and diagnostics and was instrumental in developing the regulatory framework for biotechnology, nationally and internationally; deputy assistant secretary for Health/Science and Environment from 1989–1993 where he had policy oversight for department-wide science and environmental programs and director of the Office of Emergency Preparedness and director of the National Disaster Medical System from 1993–1996 (responsible for response and recovery efforts from disasters).  

Dr. Young held a number of concurrent government positions. In 1986 he was nominated by the President and confirmed by the Senate as the US government's representative to the Executive Committee of the World Health Organization. In 1990, Dr. Young was appointed as a commissioner on the World Health Organization's Commission on Health and Environment and was technical advisor to the United Nations Conference on Environment and Development. As head of the State Department Delegation to the ad hoc Biotechnology Working Group of the Organization of Economic Cooperation and Development, Paris, France, he contributed to the development of international agreements in biotechnology. He also represented DHHS on the Council of Deputies of the National Security Council.

Dr. Young's area of research is biotechnology and pathology. He has contributed over 200 scientific to this field including development of some of the earliest cloning enzymes. Dr. Young has been involved in the policy decisions concerning biotechnology from 1974–1993. He was a member of the Asilomar Conference on recombinant DNA, chairman of the Biosafety Committee at the University of Rochester, Charter member of the Recombinant DNA Advisory Committee of the Department of Health and Human Services, coordinator of the DHHS policy on biotechnology and a member of the Biotechnology Working Group that drafted the coordinated framework on biotechnology for the federal government. He lectures on the interface of science, technology and theology at conferences and colleges.

Dr. Young's awards include membership in the Institute of Medicine of the National Academy of Sciences, honorary degrees from Christian and secular colleges and universities, Secretary's Special Citation, DHHS (presented by Secretary Bowen and by Secretary Sullivan), the Inspector General's Award for Outstanding Integrity, PHS Surgeon General's Exemplary Service Medal and the Distinguished Alumnus, SUNY Upstate Medical University 2006.

Dr. Young has served on over ten corporate Board of Directors. He is an ordained Presbyterian minister and served as vice president for Reformed Theological Seminary. His ministry focuses on recovery from grief as discussed in his book, Good Grief, Loves final gift, Eleuthera Publications 2011. He and his deceased wife of 51 years, Leanne, have 5 children, 16 grandchildren and 2 great grandchildren.

Recent Stories
Preview the Upcoming ACT Webinar Titled Immunological Assessments of Viral Vectors Expressing Multiple Cytokine Transgenes in Nonclinical Studies

ACT Signature Webinar: Early Toxicology Studies – From Design to Dose Selection: What You Need to Know

ACT Free Webinar on May 29 at 11 AM: A Regulatory and Industry Perspective on the Introduction and Application of GLP Regulations